Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Rat (Rattus) ARID3A Antikörper:
anti-Human ARID3A Antikörper:
anti-Mouse (Murine) ARID3A Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Polyclonal ARID3A Primary Antibody für ICC, IF - ABIN151747
Fukuyo, Horikoshi, Ishov, Silverstein, Nakajima: The herpes simplex virus immediate-early ubiquitin ligase ICP0 induces degradation of the ICP0 repressor protein E2FBP1. in Journal of virology 2011
Human Monoclonal ARID3A Primary Antibody für IF, IHC (p) - ABIN560650
Kang, Yeom, Kim, Kim, Lee: Expression profiling of more than 3500 proteins of MSS-type colorectal cancer by stable isotope labeling and mass spectrometry. in Journal of proteomics 2012
Cow (Bovine) Polyclonal ARID3A Primary Antibody für WB - ABIN2780661
Lin, Ippolito, Zong, Bryant, Koslovsky, Tucker: Bright/ARID3A contributes to chromatin accessibility of the immunoglobulin heavy chain enhancer. in Molecular cancer 2007
Data indicate ARID3a(+) B cells as a type of effector B cell, and link ARID3a expression in B lymphocytes to interferon alpha (IFNa (zeige IFNA Antikörper))-associated inflammatory responses in systemic lupus erythematosus (SLE).
results suggest that appropriate regulation of ARID3a is critical for normal development of both myeloid and B lineage pathways.
These data reveal new functions for ARID3a in early hematopoiesis and suggest that knowledge regarding ARID3a levels in HSPCs could be informative for applications requiring transplantation of those cells.
Systemic lupus erythematosus (SLE) patients had increased ARID3a+ B cells compared to healthy controls. ARID3a was not expressed in naive B cells of controls, but was abundant in SLE patients. Number of ARID3a+ B cells correlated with disease activity.
miR (zeige MLXIP Antikörper)-125b can act as an oncogene (zeige RAB1A Antikörper) in B-cell acute lymphoblastic leukemia by targeting ARID3a and mediating its repression.
These findings support the hypothesis that Epstein-Barr virus EBNA1 (zeige EBNA-1 Antikörper) initiates transcription at the C promoter via interactions between multiple EBNA1 (zeige EBNA-1 Antikörper) homodimers and cellular transcription such as E2F1 (zeige E2F1 Antikörper), ARID3A and Oct-2.
These results indicate both cooperative and interdependent roles for ARID3A and p53 (zeige TP53 Antikörper) in the transcriptional activation of p21(WAF1 (zeige CDKN1A Antikörper)) in response to DNA damage.
functions as a critical antagonist to the p16(INK4A (zeige CDKN2A Antikörper))-Rb tumor suppressor machinery by regulating promyelocytic leukemia protein (zeige PML Antikörper) stability
report that E2FBP1 inhibits accumulation of ICP0 RNA and, at the same time, is degraded via ICP0's herpes ubiquitin ligase 2 (HUL-2) activity upon HSV-1 infection.
Bright/ARID3a inhibition causes increased developmental plasticity in mouse and human cells.
dril1 is a novel regulator of TGF(beta (zeige TGFB1 Antikörper)) signaling and a vital component of mesodermal patterning and embryonic morphogenesis.
ARID3A is required for normal murine trophoblast development in vivo. The results reveal an essential, conserved function for ARID3A in mammalian placental development through regulation of both intrinsic and extrinsic developmental programs.
identify the Arid3a transcription factor as a key target of Let-7, whose ectopic expression is sufficient to induce B-1 development in adult pro-B cells and whose silencing by knockdown blocks B-1 development in fetal pro-B cells.
identify Arid3a as a critical regulator of TE and placental development through execution of the commitment and differentiation phases of the first cell fate decision
these results place Bright/Arid3a on a select list of transcriptional regulators required to program both hematopoietic stem cell and lineage-specific differentiation.
Id1 (zeige ID1 Antikörper) inhibited DNA binding by Dril1, and the two proteins co-localized in vitro and in vivo, providing a potential mechanism for suppression of fibrosis by Id1 (zeige ID1 Antikörper) through inhibition of the profibrotic function of Dril1.(Dril1)
The ability of Bright to enhance immunoglobulin transcription critically requires functional Bruton's tyrosine kinase (zeige BTK Antikörper) .
For IgH transactivation, Bright binds to nuclear matrix association regions.Bright actively shuttles between the nucleus and the cytoplasm, regulation of Bright's cellular localization appears to be required for its function.
Bright functions in a subset of Bruton's tyrosine kinase (zeige BTK Antikörper)-dependent pathways in vivo, particularly those responses dominated by B1 B cells.
This gene encodes a member of the ARID (AT-rich interaction domain) family of DNA binding proteins. It was found by homology to the Drosophila dead ringer gene, which is important for normal embryogenesis. Other ARID family members have roles in embryonic patterning, cell lineage gene regulation, cell cycle control, transcriptional regulation, and possibly in chromatin structure modification.
AT rich interactive domain 3A (BRIGHT-like)
, AT-rich interactive domain-containing protein 3A-like
, AT-rich interactive domain-containing protein 3A
, dead ringer homolog 1
, ARID domain-containing 3A
, ARID domain-containing protein 3A
, AT rich interactive domain 3A (BRIGHT- like) protein
, B-cell regulator of IgH transcription
, E2F-binding protein 1
, dead ringer-like 1
, dead ringer-like protein 1
, bright homolog
, AT rich interactive domain 3A (Bright like)